Tolinapant and Radiation for Cisplatin-Ineligible, Previously Untreated, Locally Advanced Head and Neck Cancer

NCT05245682 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

10

Enrollment

OTHER

Sponsor class

Conditions

Head and Neck Carcinoma of Unknown Primary
Locally Advanced Head and Neck Squamous Cell Carcinoma
Locally Advanced Hypopharyngeal Squamous Cell Carcinoma
Locally Advanced Laryngeal Squamous Cell Carcinoma
Locally Advanced Nasopharyngeal Squamous Cell Carcinoma
Locally Advanced Oropharyngeal Squamous Cell Carcinoma

Interventions

DRUG: Tolinapant
RADIATION: Radiation Therapy

Sponsor

Emory University

Collaborators

[object Object]
[object Object]